Effects of tolcapone upon soluble and membrane-bound brain and liver catechol-O-methyltransferase
- 3 March 1999
- journal article
- Published by Elsevier in Brain Research
- Vol. 821 (1) , 69-78
- https://doi.org/10.1016/s0006-8993(99)01063-x
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Effects of tolcapone in Parkinson's patients taking L‐dihydroxyphenylalanine/carbidopa and selegilineMovement Disorders, 1995
- General properties and clinical possibilities of new selective inhibitors of catechol O-methyltransferaseGeneral Pharmacology: The Vascular System, 1994
- Clinical Potential of Catechol-O-Methyltransferase (COMT) Inhibitors as Adjuvants in Parkinsonʼs DiseaseCNS Drugs, 1994
- Rationale for Selective COMT Inhibitors as Adjuncts in the Drug Treatment of Parkinson's DiseaseBasic & Clinical Pharmacology & Toxicology, 1990
- Molecular cloning and characterization of rat liver catechol-O-methyltransferaseGene, 1990
- Catechol-O-methyltransferase activity in human and rat small intestineLife Sciences, 1988
- Properties of novel effective and highly selective inhibitors of catechol-O-methyltransferaseLife Sciences, 1988
- Soluble and Particulate Forms of Rat Catechol‐O‐Methyltransferase Distinguished by Gel Electrophoresis and Immune FixationJournal of Neurochemistry, 1985
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976
- Catechol-O-methyl transferase in mouse liver plasma membranesBiochemical and Biophysical Research Communications, 1975